Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis

Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis

Although biologic therapies have changed the course of rheumatoid arthritis (RA), today's major challenge remains to identify biomarkers to target treatments to selected patient groups. Circulating micro(mi)RNAs represent a novel class of molecular biomarkers whose expression is altered in RA....

Full description

Bibliographic Details
Main Authors: Duroux-Richard, Isabelle, Pers, Yves-Marie, Fabre, Sylvie, Ammari, Meryem, Baeten, Dominique, Cartron, Guillaume, Touitou, Isabelle, Jorgensen, Christian, Apparailly, Florence
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980876/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980876/

Similar Items